Latest Articles

Early Intervention and Disease Modification in Atopic Dermatitis

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

New Horizon in management of high-risk patients with Diabetes

Dr. Hanan Taib, Consultant Family Medicine and Diabetology, Prince Sultan Military City, Riyadh, presents New Horizon in management of high-risk patients with Diabetes.

Understanding Cumulative Disease Burden in Uncontrolled AD

This evidence-based 3.17-minute video explores how uncontrolled atopic dermatitis creates cumulative disease burden beyond visible skin manifestations. Discover the hidden burden—psychological, social, and systemic impacts often overlooked—and the long-term implications of chronic inflammation. Learn to recognize progression patterns and the critical importance of early intervention strategies.

The Role of Mucus Plugging in Asthma and Its Clinical Burden

Understanding Airway Obstruction: The Role of Mucus Plugging in Asthmatic Disease

Dupilumab in Pediatric EoE: Phase 3 KIDS Study Results

This poster presentation evaluates the efficacy of dupilumab in treating eosinophilic esophagitis (EoE) in patients weighing ≥15 kg at baseline from the Phase 3 KIDS study.

Unseen Burdens: How Cumulative Life Course Impairment (CLCI) Affects Patients with Moderate-to-Severe Atopic Dermatitis (AD)

The Hidden Impact of Cumulative Life Course Impairment (CLCI) in Dermatology: An Overview